NCT04748848 2023-03-02A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidine in R/R Acute Myeloid Leukemia and Treatment-naïve Participants Not Eligible for Intensive TherapyCelgenePhase 1 Terminated1 enrolled
NCT04309084 2023-02-16Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple MyelomaCelularity IncorporatedPhase 1 Unknown29 enrolled
NCT03459170 2022-07-12Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo TransplantBellicum PharmaceuticalsPhase 1 Active not recruiting15 enrolled